GenomixThera specializes in personalized cancer treatments using CRISPR-Cas9 gene editing and quantum-guided nanoparticle delivery systems.
Genomix Thera has raised $4.9M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Genomix Thera is headquartered in Berlin, Germany.
GenomixThera specializes in personalized cancer treatments using CRISPR-Cas9 gene editing and quantum-guided nanoparticle delivery systems.
Genomix Thera is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genomix Thera — Funding & Investors." VCBacked, January 19, 2024, https://www.vcbacked.co/company/genomix-thera. Accessed October 5, 2026.
VCBacked. (2024). Genomix Thera — Funding & Investors. Retrieved October 5, 2026, from https://www.vcbacked.co/company/genomix-thera
{{cite web |title=Genomix Thera — Funding & Investors |url=https://www.vcbacked.co/company/genomix-thera |website=VCBacked |access-date=October 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated